In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Eurocept Pharmaceuticals

Division of Eurocept Group
www.eurocept.nl

Latest From Eurocept Pharmaceuticals

April CHMP Meeting: Disappointment In Advance For AB Science, Gilead Hopeful On Biktarvy

The European Medicines Agency’s CHMP is deciding the fate of several new drugs at its April meeting, which is taking place this week.

 

Drug Review Approvals

Deals Shaping The Medical Industry, April 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Deals Shaping the Medical Industry (03/2009)

The dealmaking column is a survey of recent transactions, including strategic alliances, mergers & acquisitions, and financings, in the life sciences industries. Deals are listed by the following industry sectors: in vitro diagnostics, pharmaceuticals, medical devices, and research/analytical instrumentation and reagents. All transactions are excerpted from Windhover's Strategic Transactions Database, providing comprehensive transaction coverage from 1991 to the present.
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • EuroCept BV
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Benelux
          • Netherlands
  • Parent & Subsidiaries
  • Eurocept Group
  • Senior Management
  • Mike Van Woensel, CEO
  • Contact Info
  • Eurocept Pharmaceuticals
    Phone: (31) 35 5288 377
    Trapgans 5
    Ankeveen, 1244 RL
    Netherlands
Advertisement
Advertisement
UsernamePublicRestriction

Register